| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/B978-0-12-394274-6.00006-6 |
| P698 | PubMed publication ID | 23290780 |
| P2093 | author name string | Shyam Srivats | |
| Torsten Böhler | |||
| Danielle Monteil | |||
| Silvia Ottaviani | |||
| Dmitri Pchejetski | |||
| Heba Alshaker | |||
| Lysann Sauer | |||
| P2860 | cites work | Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis | Q44987448 |
| Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes | Q56749578 | ||
| P304 | page(s) | 143-200 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Therapeutic potential of targeting SK1 in human cancers | |
| P478 | volume | 117 |
| Q38818754 | CIB1: a small protein with big ambitions |
| Q33799125 | Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1. |
| Q35532881 | Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C |
| Q46140496 | Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients |
| Q90456543 | Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors |
| Q54982231 | High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer. |
| Q50098292 | Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation |
| Q41828412 | Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II. |
| Q37697253 | Kinase inhibitors as potential agents in the treatment of multiple myeloma |
| Q35000226 | Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway |
| Q41899577 | New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth. |
| Q39203633 | Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops |
| Q26998940 | STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer |
| Q37162367 | STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. |
| Q35165322 | Simultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulin |
| Q91713420 | Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target |
| Q38931701 | Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer. |
| Q37697046 | Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma. |
| Q41977983 | Study of the expression and function of ACY1 in patients with colorectal cancer |
| Q26801886 | Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer |
| Q26748927 | The emerging role of FTY720 (Fingolimod) in cancer treatment |
| Q64111780 | Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting |
Search more.